← Back to Investors

Alexandria Venture Investments

Strategic venture capital arm of Alexandria Real Estate Equities (NYSE - ARE), the leading life science real estate company. Invests in life science companies, often current or prospective tenants of Alexandria's innovation campuses.

Location
Pasadena, USA
Founded
2006
AUM
$1.8B+
Investment Range
$5M - $50M
Portfolio Companies
6
Focus
cvc
Fund Stages
seed, series-a, series-b, series-c, growth

Portfolio Companies

NameLocationFoundedCategories
Affinia Therapeutics--
gene-therapybiotech+1
MOMA TherapeuticsCambridge, Massachusetts, USA2019
therapeuticsbiotech+3
Ventus TherapeuticsWaltham, Massachusetts, USA2018
therapeuticsbiotech+3
Capstan TherapeuticsSan Diego, California, USA2019
cell-therapygene-therapy+3
Creyon BioSan Diego, California, USA2020
ai-mltherapeutics+4
Remix TherapeuticsCambridge, Massachusetts, USA2018
rna-therapeuticsbiotech+3